Omada Health is trading at $20.72, up 11.54% in pre-market, with no confirmed company-specific explanation for the move.
- Omada Health is scheduled to report Q3 results after market close on November 5; analysts expect about $85.64 million in revenue. The report may be a focus for investors, but it is not a confirmed cause.
- Broader indices were higher, but evidence does not establish that market sentiment explains the move. Recent analyst commentary and the earnings preview predate November 4.